Nature of Disclosure: Regulatory filing providing prior intimation of an upcoming board meeting pursuant to SEBI Listing Obligations and Disclosure Requirements Regulations.
Board Meeting Details: A meeting of the Board of Directors of Fredun Pharmaceuticals Limited is scheduled to be held on Wednesday, 5th August 2026.
Agenda Items: The board will consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the first quarter ended 30th June 2026.
Regulatory Compliance: The notice is issued pursuant to Regulation 29, read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Trading Window Closure: As per SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the company shall remain closed until the expiry of 48 hours after the declaration of the financial results.
Recipient: BSE Limited, Department of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street - Fort, Mumbai - 400 001.